Alzheimer's Disease International (2015). World Alzheimer's Report. London: Alzheimer's Disease International.
Andersen, F., Viitanen, M., Halvorsen, D. S., Straume, B. and Engstad, T. A. (2011). Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern norway. BMC Geriatrics, 11, 1–7.
et al. (1992). A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. New England Journal of Medicine, 327, 168–173.
Azermai, M., Petrovic, M., Elseviers, M. M., Bourgeois, J., Van Bortel, L. M. and Vander Stichele, R. H. (2012). Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Research Reviews, 11, 78–86.
Banerjee, S. (2009). The use of Antipsychotic Medication for People with Dementia: Time for Action. London: Department of Health.
Billioti de Gage, S.
et al. (2012). Benzodiazepine use and risk of dementia: prospective population based study. BMJ, 345, e6231.
Bishara, D., Taylor, D., Howard, R. J. and Abdel-Tawab, R. (2009). Expert opinion on the management of behavioural and psychological symptoms of dementia (BPSD) and investigation into prescribing practices in the UK. International Journal of Geriatric Psychiatry, 24, 944–954.
Borbasi, S., Jones, J., Lockwood, C. and Emden, C. (2006). Health professionals’ perspectives of providing care to people with dementia in the acute setting: toward better practice. Geriatric Nursing, 27, 300–308.
et al. (2015). Non-pharmacological interventions as a best practice strategy in people with dementia living in nursing homes. A systematic review. European Geriatric Medicine, 6, 134–150.
Cahill, S., O'Shea, E. and Pierce, M. (2012). Creating Excellence in Dementia Care: A Research Review for Ireland's National Dementia Strategy. Dublin: Dementia Services Information and Development Centre (DSIDC).
Central Statistics Office (2012). Census 2011 Reports. Dublin, Ireland: Central Statistics Office.
Clegg, A. and Young, J. B. (2011). Which medications to avoid in people at risk of delirium: a systematic review. Age and Ageing, 40, 23–29.
et al. (2016). Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clinical and Experimental Research, 28, 25–35.
De Hert, M., Detraux, J., van Winkel, R., Yu, W. and Correll, C. U. (2012). Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nature Reviews Endocrinology, 8, 114–126.
de Siún, A.
et al. (2014). Irish National Audit of Dementia Care in Acute Hospitals. Cork: National Audit of Dementia Care.
Department of Health (2014). The Irish National Dementia Strategy. Dublin: Department of Health.
et al. (2016). Antipsychotic prescription amongst hospitalized patients with dementia. QJM. Epublished ahead of print, DOI: 10.1093/qjmed/hcw023.
Giron, M. S. T., Forsell, Y., Bernsten, C., Thorslund, M., Winblad, B. and Fastbom, J. (2001). Psychotropic drug use in elderly people with and without dementia. International Journal of Geriatric Psychiatry, 16, 900–906.
et al. (2012). Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Journal of Clinical Epidemiology, 65, 989–995.
Gray, S. L.
et al. (2016). Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ, 352, i90.
Hajjar, E. R., Cafiero, A. C. and Hanlon, J. T. (2007). Polypharmacy in elderly patients. The American Journal of Geriatric Pharmacotherapy, 5, 345–351.
Hartikainen, S., Lönnroos, E. and Louhivuori, K. (2007). Medication as a risk factor for falls: critical systematic review. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 62, 1172–1181.
Hartikainen, S., Rahkonen, T., Kautiainen, H. and Sulkava, R. (2003). Use of psychotropics among home-dwelling nondemented and demented elderly. International Journal of Geriatric Psychiatry, 18, 1135–1141.
Hosia-Randell, H. and Pitkälä, K. (2005). Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs & Aging, 22, 793–800.
et al. (2016). Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 12, 195–202.
Lawlor, B. (2002). Managing behavioural and psychological symptoms in dementia. The British Journal of Psychiatry: The Journal of Mental Science, 181, 463–465.
Mariani, E., Monastero, R. and Mecocci, P. (2007). Mild cognitive impairment: a systematic review. Journal of Alzheimer's Disease, 12, 23–35.
Maust, D. T., Langa, K. M., Blow, F. C. and Kales, H. C. (2016). Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA. International Journal of Geriatric Psychiatry. Epublished ahead of print, DOI: 10.1002/gps.4452.
Maust, D. T.
et al. (2015). Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry, 72, 438–445.
Mohamed, S., Rosenheck, R., Lyketsos, C. G., Kaczynski, R., Sultzer, D. L. and Schneider, L. S. (2012). Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease. Journal of Clinical Psychiatry, 73, 121–128.
Mojtabai, R. and Olfson, M. (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry, 67, 26–36.
Mueller, S. K., Sponsler, K., Kripalani, S. and Schnipper, J. L. (2012). Hospital-based medication reconciliation practices: a systematic review. Archives of Internal Medicine, 172, 1057–1069.
O'Shea, E., Manning, E., Ross, E., McErlean, S. and Timmons, S. (2015). Northern Ireland Audit of Dementia Care in Acute Hospitals. Cork: Northern Ireland Audit of Dementia.
Patterson, S. M., Hughes, C. M., Crealey, G., Cardwell, C. and Lapane, K. L. (2010). An evaluation of an adapted US model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). Journal of the American Geriatrics Society, 58, 44–53.
Porsteinsson, A. P.
et al. (2014). Effect of citalopram on agitation in alzheimer disease: the citad randomized clinical trial. JAMA, 311, 682–691.
Roe, C. M., Anderson, M. J. and Spivack, B. (2002). Use of anticholinergic medications by older adults with dementia. Journal of the American Geriatrics Society, 50, 836–842.
Rosenberg, P. B.
et al. (2010). Sertraline for the treatment of depression in Alzheimer disease. American Journal of Geriatric Psychiatry, 18, 136–145.
Royal College of Psychiatrists (2013). National Audit of Dementia Care in General Hospitals 2012-13: Second Round Audit Report and Update: Healthcare Improvement Quality Partnership.
Sampson, E. L., Blanchard, M. R., Jones, L., Tookman, A. and King, M. (2009). Dementia in the acute hospital: prospective cohort study of prevalence and mortality. British Journal of Psychiatry, 195, 61–66.
Schmader, K. E., Hanlon, J. T., Fillenbaum, G. G., Huber, M., Pieper, C. and Horner, R. (1998). Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people. Age and Ageing, 27, 493–501.
Schneider, L. S., Dagerman, K. S. and Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934–1943.
Seitz, D. P.
et al. (2013). Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. International Psychogeriatrics, 25, 185–203.
Shin, I.-S., Carter, M., Masterman, D., Fairbanks, L. and Cummings, J. L. (2005). Neuropsychiatric symptoms and quality of life in Alzheimer disease. The American Journal of Geriatric Psychiatry, 13, 469–474.
Søndergård, L., Lopez, A. G., Andersen, P. K. and Kessing, L. V. (2008). Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disorders, 10, 87–94.
et al. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the cache county study. International Journal of Geriatric Psychiatry, 23, 170–177.
Sumukadas, D., McMurdo, M. E. T., Mangoni, A. A. and Guthrie, B. (2013). Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data. Age and ageing, 43, 515–521.
et al. (2001). Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Annals of Neurology, 49, 355–361.
et al. (2015). Dementia in older people admitted to hospital: a regional multi-hospital observational study of prevalence, associations and case recognition. Age and Ageing, 44, 993–999.
Travers, C., Byrne, G., Pachana, N., Klein, K. and Gray, L. (2013). Prospective observational study of dementia and delirium in the acute hospital setting. Internal Medicine Journal, 43, 262–269.
Van den Broeck, J., Cunningham, S. A., Eeckels, R. and Herbst, K. (2005). Data cleaning: detecting, diagnosing, and editing data abnormalities. PLoS Medicine, 2, 966.
et al. (2016). Elderly patients treated with psychotropic medicines admitted to hospital: associated characteristics and inappropriate use. European Journal of Clinical Pharmacology, 72, 755–764.
Von Elm, E.
et al. (2007). The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Preventive Medicine, 45, 247–251.
Walsh, K. A., O'Riordan, D., Kearney, P. M., Timmons, S. and Byrne, S. (2016). Improving the appropriateness of prescribing in older patients: a systematic review and meta-analysis of pharmacists’ interventions in secondary care. Age and Ageing, 45, 201–209.
et al. (2010). Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. American Journal of Geriatric Psychiatry, 18, 332–340.
Wergeland, J. N., Selbæk, G., Høgset, L. D., Söderhamn, U. and Kirkevold, Ø. (2014). Dementia, neuropsychiatric symptoms, and the use of psychotropic drugs among older people who receive domiciliary care: a cross-sectional study. International Psychogeriatrics, 26, 383–391.
WHO (2015). Collaborating centre for drug statistics methodology. About the ATC/DDD system. Available at http://www.whocc.no; last accessed 1 July 2015.
Wills, P., Claesson, C. B., Fastbom, J., Fratiglioni, L., Thorslund, M. and Winblad, B. (1997). Drug use by demented and non-demented elderly people. Age and Ageing, 26, 383–391.
Wolf-Klein, G. P.
et al. (1988). Are Alzheimer patients healthier? Journal of the American Geriatrics Society, 36, 219–224.
et al. (2009). Does dementia predict adverse hospitalization outcomes? A prospective study in aged inpatients. International Journal of Geriatric Psychiatry, 24, 283–291.